8-Carboxamidocyclazocine

From WikiMD's WELLNESSPEDIA

A chemical compound related to cyclazocine

Chemical Compound
Identifiers
CAS Number
PubChem CID
ChemSpider ID
UNII
ChEBI
ChEMBL
Properties
Chemical Formula
Molar Mass
Appearance
Density
Melting Point
Boiling Point
Hazards
GHS Pictograms [[File:|50px]]
GHS Signal Word
GHS Hazard Statements
NFPA 704 [[File:|50px]]
References

8-Carboxamidocyclazocine is a chemical compound that belongs to the class of benzomorphan opioids. It is structurally related to cyclazocine, a well-known opioid receptor agonist and antagonist.

Chemical structure and properties[edit]

8-Carboxamidocyclazocine is a derivative of cyclazocine, characterized by the presence of a carboxamide group at the 8-position of the benzomorphan skeleton. This modification alters its binding affinity and activity at various opioid receptors.

Pharmacology[edit]

8-Carboxamidocyclazocine acts as a kappa-opioid receptor agonist and a mu-opioid receptor partial agonist. The kappa-opioid receptor activity is associated with its potential analgesic effects, as well as its ability to produce dysphoria and hallucinations in some cases. The mu-opioid receptor activity contributes to its analgesic properties but also limits its use due to potential for abuse and dependence.

Potential therapeutic uses[edit]

Research into 8-Carboxamidocyclazocine has focused on its potential as an analgesic with reduced abuse potential compared to traditional mu-opioid receptor agonists. Its kappa-opioid receptor activity may also make it useful in treating conditions such as depression and anxiety, although these applications are still under investigation.

Side effects and safety[edit]

As with other kappa-opioid receptor agonists, 8-Carboxamidocyclazocine may cause side effects such as dysphoria, hallucinations, and sedation. Its safety profile is not fully established, and further research is needed to determine its long-term effects and potential for abuse.

Related pages[edit]

  • 8-Carboxamidocyclazocine
    8-Carboxamidocyclazocine

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=8-Carboxamidocyclazocine&oldid=6303759"